Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Repatha on Platelet Activation in FH Patients
NCT03331666Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Nov 2018
- Primary completion
- Feb 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in familial hypercholesterolemia (FH) comparing Evolocumab Arm with Placebo Arm (2 arms). Primary endpoints: P2Y12 Reaction Units at 84 days and Aspirin Reaction Units at 84 days. Started Nov 2018; status: terminated.
02
Drugs
evolocumab
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT03331666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331666.